{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:15:24Z","timestamp":1783383324681,"version":"3.54.6"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","award":["HS058"],"award-info":[{"award-number":["HS058"]}],"id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09720-5","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:06:11Z","timestamp":1778652371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pitfalls in the reporting of clinical events in unblinded device trials: analysing performance bias in the BIO|GUARD-MI trial"],"prefix":"10.1186","volume":"27","author":[{"given":"Christian","family":"J\u00f8ns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"S\u00f8gaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Smilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161","family":"T\u00e1borsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozsef","family":"Faluk\u00f6zy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Wiemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Dahl","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrejs","family":"Erglis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muchtiar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Marti Almor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"del Prado Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Rybar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vitali Serdoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3656-6327","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the BIO|GUARD-MI study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"9720_CR1","doi-asserted-by":"crossref","unstructured":"J\u00f8ns C, S\u00f8gaard P, Behrens S, Schrader J, Mrosk S and PE Bloch Thomsen. The clinical effect of arrhythmia monitoring after myocardial infarction (BIOGUARD|MI): study protocol for a randomized controlled trial. Trials. 2019;20:563","DOI":"10.1186\/s13063-019-3644-5"},{"key":"9720_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1300074","volume":"11","author":"C J\u00f8ns","year":"2024","unstructured":"J\u00f8ns C, Bloch Thomsen PE, Riahi S, Smilde T, Bach U, Jacobsen PK, et al. Arrhythmia monitoring and outcome after myocardial infarction (BIO|GUARD-MI): a randomized trial. Front Cardiovasc Med. 2024;11:1300074. https:\/\/doi.org\/10.3389\/fcvm.2024.1300074.","journal-title":"Front Cardiovasc Med"},{"key":"9720_CR3","doi-asserted-by":"publisher","unstructured":"Barton BA. Controlling bias in randomized clinical trials. In: Piantadosi, S., Meinert, C. (eds) Principles and practice of clinical trials. Springer, Cham. 2020 https:\/\/doi.org\/10.1007\/978-3-319-52677-5_214-1","DOI":"10.1007\/978-3-319-52677-5_214-1"},{"key":"9720_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.hroo.2022.11.005","volume":"4","author":"DH Lau","year":"2022","unstructured":"Lau DH, Pierre B, Cabanas P, Martens E, Bisignani G, Hofer D, et al. Diagnostic yield of an insertable cardiac monitor in a large patient population. Heart Rhythm O2. 2022;4:97\u2013102. https:\/\/doi.org\/10.1016\/j.hroo.2022.11.005.","journal-title":"Heart Rhythm O2"},{"key":"9720_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.hroo.2022.01.010","volume":"3","author":"T Deneke","year":"2022","unstructured":"Deneke T, Cabanas P, Hofer D, et al. New-generation miniaturized insertable cardiac monitor with a long sensing vector: insertion procedure, sensing performance, and home monitoring transmission success in a real-world population. Heart Rhythm O2. 2022;3:152\u20139.","journal-title":"Heart Rhythm O2"},{"key":"9720_CR6","first-page":"i","volume":"26","author":"HO Birk","year":"2024","unstructured":"Birk HO, Vrangb\u00e6k K, Rudkj\u00f8bing A, Krasnik A, Eriksen A, Richardson E, et al. Denmark: health system review. Health Syst Transition. 2024;26:i\u2013152.","journal-title":"Health Syst Transition"},{"key":"9720_CR7","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/eurheartj\/eht071","volume":"34","author":"S Pocock","year":"2013","unstructured":"Pocock S, Calvo G, Marrugat J, Prasad K, Tavazzi L, Wallentin L, et al. International differences in treatment effect: do they really exist and why? Eur Heart J. 2013;34:1846\u201352. https:\/\/doi.org\/10.1093\/eurheartj\/eht071.","journal-title":"Eur Heart J"},{"key":"9720_CR8","doi-asserted-by":"publisher","first-page":"662775","DOI":"10.3389\/fmed.2021.662775","volume":"8","author":"HK Nielsen","year":"2021","unstructured":"Nielsen HK, DeChiaro S, Goldman B. Evaluation of consistency of treatment response across regions-the LEADER trial in relation to the ICH E17 guideline. Front Med. 2021;8:662775. https:\/\/doi.org\/10.3389\/fmed.2021.662775.","journal-title":"Front Med"},{"key":"9720_CR9","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDctcs2100007","volume":"1","author":"MA Pfeffer","year":"2022","unstructured":"Pfeffer MA, Clagget B. Behind the scenes of TOPCAT \u2014 bending to inform. NEJM Evid. 2022;1:10.1056\/EVIDctcs2100007.","journal-title":"NEJM Evid"},{"key":"9720_CR10","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1056\/NEJMra1510065","volume":"375","author":"S Yusuf","year":"2016","unstructured":"Yusuf S, Wittes J. Interpreting geographic variations in results of randomized, controlled trials. N Engl J Med. 2016;375:2263\u201371. https:\/\/doi.org\/10.1056\/NEJMra1510065.","journal-title":"N Engl J Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09720-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09720-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09720-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:32:48Z","timestamp":1783380768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09720-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9720"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09720-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by ethics committees relevant to all involved hospitals. A list is available upon request from the first author. The study was conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SB reports lecture fees and travel costs from Biotronik in the context of this study, and lecture fees from Astra Zeneca, Bayer, Berlin Chemie, Boehringer, Bristol Myers Squibb, and Novartis, and DSMB or advisory board membership fees from Astra Zeneca, Bayer, Berlin Chemie, Boehringer, Bristol Myers Squibb, and Novartis. LVS report lecture fees and travel costs from Abbott Medical. JS is an employee of Biotronik. PS, TS, MT, JF, MW, PDC, AE, MK, JMA, SdPD, IR and CJ declare no conflict of interest. All clinical authors received patient fees for the reporting of study-related data, which were paid to their institutions.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"471"}}